These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7712130)

  • 21. Conformation of a heptapeptide substrate bound to protein farnesyltransferase.
    Stradley SJ; Rizo J; Gierasch LM
    Biochemistry; 1993 Nov; 32(47):12586-90. PubMed ID: 8251476
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synthesis and biological activity of semipeptoid farnesyltransferase inhibitors.
    Reuveni H; Gitler A; Poradosu E; Gilon C; Levitzki A
    Bioorg Med Chem; 1997 Jan; 5(1):85-92. PubMed ID: 9043660
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Synthesis and conformational analysis of peptide inhibitors of farnesyltransferase.
    Byk G; Lelievre Y; Duchesne M; Clerc FF; Scherman D; Guitton JD
    Bioorg Med Chem; 1997 Jan; 5(1):115-24. PubMed ID: 9043663
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformation.
    Carboni JM; Yan N; Cox AD; Bustelo X; Graham SM; Lynch MJ; Weinmann R; Seizinger BR; Der CJ; Barbacid M
    Oncogene; 1995 May; 10(10):1905-13. PubMed ID: 7761092
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
    Manne V; Yan N; Carboni JM; Tuomari AV; Ricca CS; Brown JG; Andahazy ML; Schmidt RJ; Patel D; Zahler R
    Oncogene; 1995 May; 10(9):1763-79. PubMed ID: 7753553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CAAX peptidomimetic FTI-244 decreases platelet-derived growth factor receptor tyrosine phosphorylation levels and inhibits stimulation of phosphatidylinositol 3-kinase but not mitogen-activated protein kinase.
    McGuire TF; Qian Y; Blaskovich MA; Fossum RD; Sun J; Marlowe T; Corey SJ; Wathen SP; Vogt A; Hamilton AD
    Biochem Biophys Res Commun; 1995 Sep; 214(1):295-303. PubMed ID: 7669049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activated Drosophila Ras1 is selectively suppressed by isoprenyl transferase inhibitors.
    Kauffmann RC; Qian Y; Vogt A; Sebti SM; Hamilton AD; Carthew RW
    Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10919-23. PubMed ID: 7479910
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Structure-activity relationships of cysteine-lacking pentapeptide derivatives that inhibit ras farnesyltransferase.
    Leonard DM; Shuler KR; Poulter CJ; Eaton SR; Sawyer TK; Hodges JC; Su TZ; Scholten JD; Gowan RC; Sebolt-Leopold JS; Doherty AM
    J Med Chem; 1997 Jan; 40(2):192-200. PubMed ID: 9003517
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Farnesyltransferase inhibitors block the neurofibromatosis type I (NF1) malignant phenotype.
    Yan N; Ricca C; Fletcher J; Glover T; Seizinger BR; Manne V
    Cancer Res; 1995 Aug; 55(16):3569-75. PubMed ID: 7627966
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Non-thiol farnesyltransferase inhibitors: utilization of an aryl binding site by 5-arylacryloylaminobenzophenones.
    Mitsch A; Böhm M; Wissner P; Sattler I; Schlitzer M
    Bioorg Med Chem; 2002 Aug; 10(8):2657-62. PubMed ID: 12057654
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Synthesis and biological activity of ras farnesyl protein transferase inhibitors. Tetrapeptide analogs with amino methyl and carbon linkages.
    Wai JS; Bamberger DL; Fisher TE; Graham SL; Smith RL; Gibbs JB; Mosser SD; Oliff AI; Pompliano DL; Rands E
    Bioorg Med Chem; 1994 Sep; 2(9):939-47. PubMed ID: 7712129
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Discovery of (R)-7-cyano-2,3,4, 5-tetrahydro-1-(1H-imidazol-4-ylmethyl)-3- (phenylmethyl)-4-(2-thienylsulfonyl)-1H-1,4-benzodiazepine (BMS-214662), a farnesyltransferase inhibitor with potent preclinical antitumor activity.
    Hunt JT; Ding CZ; Batorsky R; Bednarz M; Bhide R; Cho Y; Chong S; Chao S; Gullo-Brown J; Guo P; Kim SH; Lee FY; Leftheris K; Miller A; Mitt T; Patel M; Penhallow BA; Ricca C; Rose WC; Schmidt R; Slusarchyk WA; Vite G; Manne V
    J Med Chem; 2000 Oct; 43(20):3587-95. PubMed ID: 11020273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 7-imidazolylalkanamido-1-carboxylalkylbenzo-diazepine, a novel series of farnesyltransferase inhibitors.
    Wan SB; Chu FM; Guo ZR
    Yao Xue Xue Bao; 2002 Jul; 37(7):516-21. PubMed ID: 12914320
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of highly potent inhibitors of Ras farnesyltransferase possessing cellular and in vivo activity.
    Leftheris K; Kline T; Vite GD; Cho YH; Bhide RS; Patel DV; Patel MM; Schmidt RJ; Weller HN; Andahazy ML; Carboni JM; Gullo-Brown JL; Lee FY; Ricca C; Rose WC; Yan N; Barbacid M; Hunt JT; Meyers CA; Seizinger BR; Zahler R; Manne V
    J Med Chem; 1996 Jan; 39(1):224-36. PubMed ID: 8568812
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Discovery and structure-activity relationships of imidazole-containing tetrahydrobenzodiazepine inhibitors of farnesyltransferase.
    Ding CZ; Batorsky R; Bhide R; Chao HJ; Cho Y; Chong S; Gullo-Brown J; Guo P; Kim SH; Lee F; Leftheris K; Miller A; Mitt T; Patel M; Penhallow BA; Ricca C; Rose WC; Schmidt R; Slusarchyk WA; Vite G; Yan N; Manne V; Hunt JT
    J Med Chem; 1999 Dec; 42(25):5241-53. PubMed ID: 10602709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Development of tripeptidyl farnesyltransferase inhibitors.
    Lee HY; Sohn JH; Kwon BM
    Bioorg Med Chem Lett; 2002 Jun; 12(12):1599-602. PubMed ID: 12039571
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Anti tumor activity of farnesyl transferase inhibitor].
    Yoshimatsu K; Nagasu T
    Gan To Kagaku Ryoho; 1997 Jan; 24(2):145-55. PubMed ID: 9030225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Farnesylation of p21 Ras proteins in Xenopus oocytes.
    Zhao J; Kung HF; Manne V
    Cell Mol Biol Res; 1994; 40(4):313-21. PubMed ID: 7866432
    [TBL] [Abstract][Full Text] [Related]  

  • 39. NMR studies of novel inhibitors bound to farnesyl-protein transferase.
    Koblan KS; Culberson JC; Desolms SJ; Giuliani EA; Mosser SD; Omer CA; Pitzenberger SM; Bogusky MJ
    Protein Sci; 1995 Apr; 4(4):681-8. PubMed ID: 7613466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. In vitro and in vivo antimalarial activity of peptidomimetic protein farnesyltransferase inhibitors with improved membrane permeability.
    Carrico D; Ohkanda J; Kendrick H; Yokoyama K; Blaskovich MA; Bucher CJ; Buckner FS; Van Voorhis WC; Chakrabarti D; Croft SL; Gelb MH; Sebti SM; Hamilton AD
    Bioorg Med Chem; 2004 Dec; 12(24):6517-26. PubMed ID: 15556768
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.